What Is Tesamorelin? Research Background and Approved-Drug Context
Tesamorelin is a GHRH analog and, unusually for this category, an FDA-approved drug for one narrow indication. What it is, what the trials actually measured, and
Educational, research-only overviews of peptides, blends, testing methods, and how to read the scientific literature. For laboratory and research use only.
Tesamorelin is a GHRH analog and, unusually for this category, an FDA-approved drug for one narrow indication. What it is, what the trials actually measured, and
Semax and Selank are sibling peptides from the same Russian institute, sharing the same stabilising tail but built from different parent molecules. A factual, research-only comparison
Semax is a synthetic heptapeptide derived from ACTH, developed in Russia. What it is, why it has no hormonal activity, what the neurotrophin research examines, and
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. What it is, how large its literature actually is, what the NNMT research examines, and what none
Selank is a synthetic heptapeptide analog of tuftsin developed in Russia. What it is, what the published research examines, why nearly all of that research is
KPV is the C-terminal tripeptide of alpha-MSH. What it is, what the published inflammatory and mucosal research examines, its regulatory status, and what that literature does
CJC-1295 is a growth-hormone-releasing hormone analog. What it is, what the DAC modification actually changes, what the published human and animal studies examined, and what that
NAD+ is a coenzyme found in every living cell, not a peptide. What it is, what the published literature examines, where the human evidence actually sits,
KLOW and GLOW share the same three-peptide base. KLOW adds KPV, taking the vial from 70 mg to 80 mg. A factual, research-only comparison of composition,
Discount Applied Successfully!
Your savings have been added to the cart.